Endotoxins (lipopolysaccharides, LPS) are potent bacterial poisons always present within the intestines in considerable amounts. Several pathophysiological conditions such as hypovolaemia, hypoxia, intestinal ischaemia, burns and radiation lead to a breakdown in the barrier and depending upon the extent of the injury, endotoxins enter the systemic circulation in increasing amounts. Antibiotics do not inactivate the endotoxins which continue to exert their toxic effects leading to nausea, vomiting, diarrhoea, fever, disseminated intravascular coagulation, vascular collapse and organ failure. When nonabsorbable antibiotics are given prior to the insult, systemic endotoxaemia is prevented. Immunotherapy, using anti-lipopolysaccharide IgG, inactivates plasma endotoxins, destroys gram-negative bacteria and opsonises them and may become a major form of therapy. An outline of endotoxin and anti-lipopolysaccharide and its importance to the anaesthetist and intensive care specialist is presented.
groups. These polysaccharides render chemical stability to LPS and protect the lipid A from host-defences. Although each strain of gram-negative bacteria produces its own specific LPS which is unique -mainly in relation to the '0' antigenic regions -there are certain chemical similarities among the LPSs prepared from a wide range of gramnegative bacteria. The interested reader is asked to review LPS chemistry and structure in the excellent review by Reitschel et al. I Endotoxins are highly toxic and can kill humans and many animals at concentrations as low as one billionth of a gram per millilitre (1.0 nglml).2 Endotoxins are, furthermore, so chemically stable that they can be boiled without losing much of their toxicity. I In fact, this is how some endotoxins are made commercially; the bacteria are simply boiled and the endotoxin isolated.
Endotoxins are released into their milieu when gram-negative bacteria die. It is now widely believed among researchers that the most important cause of the high morbidity and mortality of various disease processes, like septicaemia or septic shock, is the excess amount of endotoxins in the systemic circulation. 3 J acob Fine (personal communication) found that 20 out of 35 patients who died after non-septic shock as a result of accidents, burns and multiple trauma had lethal amounts of endotoxins in their tissues at the time of death, yet they were negative for gram-negative bacteraemia. He therefore concluded that endotoxaemia is an important contributor to the mortality and morbidity in non-septic as well as septic shock. Hence, the production of antiendotoxin antibodies (anti-LPS) used to inactivate excessive plasma levels of LPS could therefore possibily be of therapeutic benefit. This contention is supported by the early work of Zinner and McCabe 4 and of Y oung 5 and colleagues. They showed that those patients with low serum levels of anti-LPS antibodies had a 54% mortality, while those with a high level of 'natural' anti-LPS antibodies had only 9% mortality and a much reduced severity of symptoms. More recently, clinically relevant anti-LPS IgG concentrations were shown to inactivate LPS in vitro (Gaffin SL, Ledney D. In preparation).
Mechanism of action of endotoxin
While there is no general agreement on exactly how endotoxin kills, in the early stages of endotoxaemia it appears that in a most important early step, LPS causes inappropriate activation of granulocytes which secrete 'cachectin' (tumor necrosis factor). 6 This in turn leads to a massive release of vasoactive agents such as catecholamines, thromboxanes, prostaglandins and endogenous opiates. 7 • 8 In our opinion, a most important subsequent step is the contraction away from each other of endothelial cells lining the capillaries. 9 This leaves 'holes' in the capillary walls through which fluid can easily flow, meaning that plasma can now more easily leave the circulation into the tissue spaces causing oedema, hypovolaemia and haemoconcentration.
LPS Determinations
Many conclusions here depend upon the availability of a reproducible and accurate procedure for determining LPS concentrations in plasma. Historically, the limulus amoebocyte lysate (LAL) 'clot' test was used, but with poor reproducibility from laboratory to laboratory. Today the chromogenic substrate modification of the LAL test has proved to be highly reliable lo providing the investigator has previously seen it performed in an experienced laboratory. In our opinion, if one simply follows the instructions of commercial LAL kits, an expensive failure usually results.
Factors increasing endotoxin concentration
Antibiotics, while destroying gram-negative bacteria in the plasma, have been shown to increase circulating LPS concentration. II ,12 Unfortunately, conventional antibiotics have no neutralising effect on endotoxins. In some cases, the liberation of free endotoxins by killed bacteria has been so great that treated patients have suddenly gone into endotoxic shock. 13 This may possibly explain the sudden deterioration occasionally observed in some patients suffering from gram-negative bacteraemia following antibiotics. In these cases, a negative bacterial blood culture is often obtained.
Gram-negative bacteria can cause an increase in plasma endotoxin concentrations even without antibiotic treatment. An important relationship between plasma LPS concentration and E. coli concentration has recently been reported in experiments in monkeys.14 These primates received an LD 100 dose of live E. coli bacteria intravenously via an infusion over one hour. The concentration of plasma LPS, anti-LPS IgG and viable E. coli colonies in blood were determined over a six-to eight-hour period until death. Viable circulating E. coli colonies increased significantly from baseline (P < 0.001) during the infusion to a maximum and thereafter fell precipitously over a sixtyminute period. At the time of death, there were zero to less than ten viable E. coli organisms per millilitre blood. On the other hand, during the E. coli infusion period, the plasma LPS Anaesthesia and Intensive Care. Vol. /7. No. I. February. /989 concentration increased while the concentration of 'natural' anti-LPS IgG decreased (P < 0.005). Subsequently, the plasma LPS concentration of each monkey remained high until death. It was concluded that elevated plasma LPS concentrations appeared to be the more significant circulating pathogen during gram-negative bacterial shock and this supports the proposed close association between plasma LPS, morbidity and mortality in septic shock. 3 Other sources of increased plasma endotoxin concentration must also be considered, such as surface infections (burn, septic focus), but probably the most important source is the intestines. The intestines always contain gram-negative bacteria, and therefore a large amount of endotoxin. But while LPS is within the gut lumen it is completely harmless. If small amounts of LPS are released into the portal circulation, the liver is normally able to handle and detoxify it. The integrity of the intestinal wall, i.e. its ability to prevent endotoxin from leaking out into the circulation, depends on several factors. Among those that will tend to increase plasma endotoxin concentration include intestinal ischaemia,ls hypoxia,16 hyperpyrexia,17-22 parasites,23 ionizing radiation,24 burns,2s vasoactive agents 26 and insufficient bile salts.27 Most of these adverse factors damage the intestinal wall and lead to an increased leakage of endotoxins out of the gut and into the circulation. If massive amounts come out at one time, they may overwhelm the liver's detoxification capacity ahd lead to endotoxaemia.
We have measured directly the time course of endotoxaemia following intestinal ischaemia in cats. 15 The superior mesenteric artery was occluded for one hour as this is a recognised experimental model to produce aseptic shock. The endotoxins in plasma were measured before, during and after the occlusion. During the baseline period and most of the occlusion period, endotoxin levels in plasma remained low. Towards the end of the occlusion period there was a slight rise. Following release of the clamp and reperfusion of the intestine with fresh oxygenated blood, there was a large rise in the plasma endotoxin concentration to near-Anaesthesia and Intensive Care. Vol. 17. No. I. FebruarJ '. 1989 lethal or lethal levels. In the same model, we studied the effect of administering specific antibodies to LPS shortly after release of occlusion. Endotoxin levels were dramatically reduced. Interestingly, the corticosteroid methylprednisolone (Solumedrol) (40 mg/kg) given at the same time in a similar model has the same effect, hence corticosteroid prophylaxis also prevented the LPS peak following release of the occlusion. 28 This may well account for the protective effect of corticosteroids . reported for sepsis in experimental animals but not in man. The same results were also seen with prophylactic oral kanamycin and kaolin mixture administered over seven days. 29 The latter is known to bind to toxins. 30 Both faecal bacterial count and LPS concentration were were reduced by a factor of 400; hence, there was no rise in plasma LPS after reperfusion. Thus, prophylactic oral antibiotics may prove to have therapeutic implications in, for example, gastro-intestinal surgery.29 (N.B. If kanamycin alone had been given as a one-shot intravenous bolus, then the LPS concentration would have risen.)
During hypoxia (FI02 = 0.13) in monkeys, plasma LPS concentration increased within fifteen to twenty niinutes. 16 We believe this is caused by a hypoxaemic reflex which reduces splanchnic blood flow. Again, if anti-LPS was given prior to the hypoxic insult, little rise in endotoxins was seen. 16 These results may prove important in relation to both patients and subjects at risk from hypoxia. We also irradiated monkeys prior to the hypoxic insult to observe the effect of reducing reticuloendothelial function. In cases where monkeys had received 2.0 Gy (200 rads) whole body X-radiation, the LPS increased to a much higher level and persisted for a much longer time compared with that following standard hypoxia. 16 In a recent study, we showed that heat stress causes an increased plasma LPS concentration which is intestinal in origin. 17 In one series, eight monkeys were used: four acted as controls, while the other four received, on five consecutive days, oral kanamycin before being heat-stressed. Despite heating the animals who had received kanamycin to a rectal temperature of 44.5°C, no increase in plasma LPS levels was seen -a result which was in sharp contrast to the control group where the plasma LPS increased significantly.
Of further interest was the finding that the cardiovascular parameters during heat-stress were more unstable in the control group and began to deteriorate at a lower rectal temperature than in the kanamycin group. Further studies are in progress to examine malignant hyperpyrexia in experimental pigs.
Death in humans from ionizing radiation overexposure in the 3-8 Gy (300-800 rad) range is in part due to secondary gramnegati ve bacterial infection and endotoxemia. 31 It has been shown that conventional antibiotic therapy for these infections is only partially effective, since, as mentioned, antibiotics may destroy gramnegative bacteria but have no effect on the highly toxic LPS released from the killed bacteria.
In a study where mice were irradiated with 6.3 Gy (630 rad) and six days later received equine anti-LPS hyperimmune plasma, control plasma or saline, the mortalities in the three groups were 58%, 92% and 79% respectively, (P< 0.01). 24 Thus, this study suggests that anti-LPS may prove to be useful as an adjunct to conventional therapy in treating radiation sickness.
Another cause for endotoxaemia may be direct intestinal damage caused by helminthiasis. In a study of captured wild vervet monkeys, their mean plasma LPS concentration prior to deworming was 0.083 ng/mt. This value was higher than those found in noninfested monkeys, dogs and horses. After deworming, the mean plasma LPS concentration was significantly reduced to 0.04 ng/ml (P< 0.005). 23 It has also been shown that infusing vasoactive agents (epinephrine, norepinephrine, serotonin, bradykinin or histamine, 0.1 mglkg in 5 ml saline) into the systemic circulation damages the permeability properties of the intestines so that endotoxins can leak out. 26 In keeping with the above, large burns appear to cause the local release of unidentified vasoactive agents which then circulate into the intestines and damage their permeability properties, permitting, in turn, entry of endotoxins. 25 Hence, endotoxaemia that follows a large burn is caused not only from invasive bacteria but also from the entry of endotoxins from the intestines.
Among the very few natural products which can readily inactivate endotoxin are bile salts.27 It appears that bile salts form hydrophobic bonds with the lipid A portion of the endotoxin and disrupt and shield the toxic regions within lipid A from interaction with important cellular structures. The bile salts normally present in the intestines of a healthy person render a large proportion of the endotoxins inactive. However, should there be a reduction in the amount of bile salts following for example obstructive jaundice, then the amount of actively toxic endotoxin would be substantially greater and, hence, the amount of active endotoxin leaking out would be much increased.
Daily and colleagues 32 showed that all the animals previously exposed to hyperbaric environments at + 15 atmospheres developed endotoxaemia and bacteraemia. This is believed to be due to an increased rate of endotoxin leakage from the intestines, although the mechanism for this increased leakage is not known. On the other hand, in the case of a rapid decompression, bubbles are formed which probably interrupt the splanchnic microcirculation and thus probably causes the endotoxaemia usually seen in such cases. 33
The prevention of plasma endotoxaemia
There are at least two ways of preventing endotoxaemia: one is to sterilise the gut with antibiotics, thereby eliminating gramnegative bacteria, and hence endotoxins, the latter being mopped up mainly by available bile acids;27 the other is to parenterally administer anti-LPS antibodies which bind directly with the LPS.
Gut sterilisation
We have shown that prophylactic oral administration of non-absorbable antibiotics to monkeys subjected to shock induced by occlusion of the superior mesenteric artery completely prevented the increase in plasma LPS concentration seen in all monkeys not pretreated (P < 0.001). 29 The beneficial effects of prophylactic nonabsorbable Anaesthesia and Intensive Care, Vol. 17, No. 1, February, 1989 antibiotics have also been shown in rabbits who have endotoxaemia caused by superior mesenteric artery occlusion shock, vasoactive agents and/or E. coli peritonitis. 34 A selective parenteral and enteral anti-sepsis regimen was applied to patients admitted to a general intensive therapy unit. 35 This included the use of polymyxin, an anti-endotoxin agent (seldom used because of its nephrotoxic activity). These patients had a reduction in incidence of acquired infection and mortality.
Anti-LPS therapy
A practical immune therapy specifically directed to the LPS has long been under investigation. The problem has been to produce effective and broad-spectrum human anti-LPS antibodies in large amounts. Ziegler and colleagues 36 produced a hyperimmune serum to the toxic 'core' region of LPS. Its administration reduced the mortality from gram-negative bacteraemia by 50% and if the patient went into severe shock, then the chances of recovery were 2.8 times better than if he had received normal serum. However, other groups have not reproduced these findings. 37 In a British study on patients in India with large surface area burns, mortality was dramatically reduced by administration of as little as 0.6-1.5 ml high titre antipseudomonas immunoglobulin. 38 At present, such antibodies are not commercially available for clinical use. However, Gaffin found by simply screening blood units in blood banks in Israel that 7-8% of these units contained clinically useful high concentrations of antibodies to endotoxin. 39 This work led to the feasibility of large-scale production of anti-endotoxin antibodies in blood banks. 40 It was found that LPS-specific antibodies present in a single donated unit of plasma could bind to endotoxins from several bacterial strains and species. 41 A final product of hundreds of pooled donated plasma units was broad spectrum in character. In an open study, anti-LPS administration reduced mortality in patients suffering from septic shock of obstetrical and gynaecological origin from 40% to 4.7%.42 Double-blind clinical trials testing the effectiveness of this high titre globulin fraction are now under way.
It is important to recognise that anti-LPS antibodies not only inactivate endotoxins but Anaesthesia and Intensive Care. Vol. 17. No. I. February. 1989 also actually kill and lyse a wide range of gramnegative bacteria, including E. coli, klebsiella and pseudomonas, by means of complement activation. 43 . 44 Furthermore, anti-LPS increased the rate of ingestion of E. coli by human neutrophilis. 45 Equine antibodies of this type have already been successfully used to treat racehorses suffering from endotoxaemia which is otherwise rapidly fata1. 46 Equine anti-LPS antibody preparations have been in routine clinical use in veterinary medical practice in South Africa since 1983, with success in treating a variety of LPS-mediated diseases, including canine parvo virus,47 haemorrhagic enteritis,48 arthritis 49 and pyothorax (Wessels, unpublished observations). Furthermore, it reduced mortality from radiation sickness in mice 24 and from intestinal ischaemia in rabbits. 50 A Canadian group investigated a number of antibody preparations to treat septic shock in rodents and found our anti-LPS to be the most effective." Because of a number of successful applications, 52 human anti-LPS antibodies 41 are currently produced on a commercial scale in Denmark (Nordisk Gentofte). Further work evaluating anti-LPS both as a prophylactic and therapeutic measure is awaited with great interest.
